doi: 10.1056/NEJMoa240334 Summary Keywords Prader-Willi syndrome, obesity, type 2 diabetes mellitus, GLP-1 RA, semaglutide, case report Citation Dinoi E, Daniele G, Michelucci A, Baldinotti F, Campi F, Marchetti P, Del Prato S and Dardano A (2025) Efficacy and safety of once-weekly semaglutide monotherapy in a young subject with Prader-Willi syndrome, obesity, and type 2 diabetes: a case report
Seek urgent advice if you experience rapid, unintentional weight loss whilst breastfeeding, as this may indicate inadequate caloric intake, illness, or postpartum thyroid dysfunction
Research protocols often begin with 0.25mg and may scale to 0.5mg or 1mg, depending on the experimental model and study goals
This is the same mechanism targeted by topical brightening agents, delivered systemically instead, and the effect is best understood as a gradual, cumulative brightening support across a series rather than an overnight change
By directly stimulating arousal pathways in the brain, Bremelanotide (PT-141) offers a natural way to support sexual desire, making it a valuable option for individuals seeking to enhance their sexual wellness
